Yield10 Bioscience Announces Proposed Public Offering of Common Stock
January 29 2021 - 4:53PM
Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience
company, today announced it has commenced an underwritten public
offering of shares of its common stock. The public offering is
subject to market conditions, and there can be no assurance as to
whether or when the public offering may be completed, or the actual
size or terms of the public offering.
Maxim Group LLC is acting as the sole book-running manager for
the public offering.
The public offering is being made pursuant to an effective shelf
registration statement on Form S-3 that was filed with the U.S.
Securities and Exchange Commission (SEC) on April 1, 2020 and
declared effective on April 10, 2020. A preliminary prospectus
supplement describing the terms of the public offering will be
filed with the SEC and will form a part of the effective
registration statement. Copies of the preliminary prospectus
supplement and accompanying prospectus relating to the public
offering may be obtained, when available, by contacting Maxim Group
LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174, or by
telephone at (212) 895-3745.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to the registration or
qualification under the securities laws of any such state or
jurisdiction.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
developing crop innovations aligned with trends in global food
security, social responsibility, and sustainability. The Company is
using its “Trait Factory,” a differentiated trait gene discovery
platform including the “GRAIN” big data mining trait gene discovery
tool as well as the Camelina oilseed “Fast Field Testing” system,
to develop improved Camelina varieties to produce proprietary
products, and to produce high value seed traits for the agriculture
and food industries. The Company’s goals are to efficiently develop
and commercialize a high value crop products business based on
superior varieties of Camelina for producing feedstock oils,
nutritional oils, and PHA bioplastics. As a path toward
commercialization of novel traits, Yield10 is pursuing a partnering
approach with major agricultural companies to drive new traits into
development for canola, soybean, corn, and other commercial crops.
Yield10 is headquartered in Woburn, MA and has an Oilseeds Center
of Excellence in Saskatoon, Canada.
For more information about the company, please visit
www.yield10bio.com, or follow the Company on Twitter, Facebook and
LinkedIn.
(YTEN-G)
Safe Harbor for Forward-Looking
Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, the completion of the proposed public offering
described in this press release, constitute forward-looking
statements. Such forward-looking statements are subject to a number
of risks and uncertainties that could cause actual results to
differ materially from those anticipated, including the risks and
uncertainties detailed in Yield10 Bioscience's filings with the
Securities and Exchange Commission. Yield10 assumes no obligation
to update any forward-looking information contained in this press
release or with respect to the matters described
herein.
Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561)
479-8566, brets@coreir.com Managing Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com
FischTank PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024